Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Vanda Pharmaceuticals Inc Share Price

VNDA

NMQ

$6.2

+$0.11

(1.81%)

Industry: Biotechnology Sector: Health Care

Vanda Pharmaceuticals Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Vanda Pharmaceuticals Inc Share Price Chart

Vanda Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$359.97M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

1.76M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.58

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$3.81 L

$9.6 H

$6.2

About Vanda Pharmaceuticals Inc, Common Stock

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson's disease psychosis, as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Ponvory for the treatment of psoriasis and ulcerative colitis. Its pipeline products include HETLIOZ (tasimelteon) to treat jet lag disorder, insomnia, delayed sleep phase disorder, sleep disturbances in autism spectrum disorder, and pediatric Non-24; Fanapt (iloperidone) a LAI formulation to treat schizophrenia; Bysanti for the acute treatment of bipolar I disorder, schizophrenia, and major depressive disorder; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist to treat gastroparesis, motion sickness, and atopic dermatitis. The company's pipeline products also include Imsidolimab, an IL-36R antagonist, for the treatment of generalized pustular psoriasis; VTR-297, a small molecule histone deacetylase inhibitor to treat hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist to treat performance anxiety and psychiatric disorders. In addition, it offers a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors that include VSJ-110 for the treatment of dry eye and ocular inflammation; VPO-227 for the treatment of secretory diarrhea disorders comprising cholera; Antisense oligonucleotide molecules, including VCA-894A for the treatment of Charcot-Marie-Tooth Disease and Type 2S (CMT2S); and VGT-1849A for the treatment of polycythemia vera. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia. more

Industry: BiotechnologySector: Health Care

Vanda Pharmaceuticals Inc Stock Returns

Time Frame	VNDA	Sector	S&P500
1-Week Return	-16.44%	1.51%	-1.5%
1-Month Return	-19.58%	1.46%	0.6%
3-Month Return	40.91%	3.94%	2.43%
6-Month Return	35.96%	16.03%	6.01%
1-Year Return	39.01%	9.1%	11.48%
3-Year Return	-12.18%	19.46%	67.52%
5-Year Return	-67.4%	35.29%	73.75%
10-Year Return	-24.57%	137.42%	254.46%

Time Frame	VNDA	Sector	S&P500
1-Week Return	-99.99%	118.47%	-54.53%
1-Month Return	-92.94%	19.29%	7.55%
3-Month Return	301.83%	16.97%	10.23%
6-Month Return	86.44%	35.19%	12.56%
1-Year Return	39.01%	9.10%	11.48%
3-Year Return	-4.24%	6.11%	18.77%
5-Year Return	-20.08%	6.23%	11.68%
10-Year Return	-2.78%	9.03%	13.49%

Vanda Pharmaceuticals Inc Financials

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Total Revenue	268.68M	254.38M	192.64M	198.77M	216.10M	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.68,"profit":true},{"date":"2023-12-31","value":71.7,"profit":true},{"date":"2024-12-31","value":73.98,"profit":true},{"date":"2025-12-31","value":80.43,"profit":true}]
Cost of Revenue	25.63M	24.28M	17.57M	11.31M	13.04M	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.74,"profit":true},{"date":"2023-12-31","value":68.57,"profit":true},{"date":"2024-12-31","value":44.15,"profit":true},{"date":"2025-12-31","value":50.9,"profit":true}]
Gross Profit	243.05M	230.10M	192.64M	187.46M	203.06M	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.67,"profit":true},{"date":"2023-12-31","value":79.26,"profit":true},{"date":"2024-12-31","value":77.13,"profit":true},{"date":"2025-12-31","value":83.55,"profit":true}]
Gross Margin	90.46%	90.45%	100.00%	94.31%	93.96%	[{"date":"2021-12-31","value":90.46,"profit":true},{"date":"2022-12-31","value":90.45,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":94.31,"profit":true},{"date":"2025-12-31","value":93.96,"profit":true}]

Operating Expenses	200.89M	223.77M	206.59M	228.12M	354.23M	[{"date":"2021-12-31","value":56.71,"profit":true},{"date":"2022-12-31","value":63.17,"profit":true},{"date":"2023-12-31","value":58.32,"profit":true},{"date":"2024-12-31","value":64.4,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Income	42.16M	6.33M	(13.95M)	(40.66M)	(151.17M)	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":15.01,"profit":true},{"date":"2023-12-31","value":-33.09,"profit":false},{"date":"2024-12-31","value":-96.43,"profit":false},{"date":"2025-12-31","value":-358.52,"profit":false}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Pre-Tax Income	42.36M	11.30M	6.34M	(22.92M)	(138.65M)	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":26.67,"profit":true},{"date":"2023-12-31","value":14.96,"profit":true},{"date":"2024-12-31","value":-54.1,"profit":false},{"date":"2025-12-31","value":-327.28,"profit":false}]
Income Taxes	9.21M	5.03M	3.83M	(4.02M)	81.83M	[{"date":"2021-12-31","value":11.26,"profit":true},{"date":"2022-12-31","value":6.14,"profit":true},{"date":"2023-12-31","value":4.68,"profit":true},{"date":"2024-12-31","value":-4.91,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Income From Continuous Operations	33.15M	6.28M	11.77M	(18.90M)	(220.47M)	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":18.93,"profit":true},{"date":"2023-12-31","value":35.5,"profit":true},{"date":"2024-12-31","value":-57.01,"profit":false},{"date":"2025-12-31","value":-665.04,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	33.15M	6.28M	2.51M	(18.90M)	(220.47M)	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":18.93,"profit":true},{"date":"2023-12-31","value":7.57,"profit":true},{"date":"2024-12-31","value":-57.01,"profit":false},{"date":"2025-12-31","value":-665.04,"profit":false}]

EPS (Diluted)	0.58	0.12	0.05	(0.32)	(3.73)	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":20.69,"profit":true},{"date":"2023-12-31","value":9.03,"profit":true},{"date":"2024-12-31","value":-55.48,"profit":false},{"date":"2025-12-31","value":-643.1,"profit":false}]

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Total Revenue	-	(5.32%)	(24.27%)	3.18%	8.72%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-61.03,"profit":false},{"date":"2023-12-31","value":-278.34,"profit":false},{"date":"2024-12-31","value":36.5,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Cost of Revenue	-	(5.26%)	(27.63%)	(35.62%)	15.29%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-34.37,"profit":false},{"date":"2023-12-31","value":-180.67,"profit":false},{"date":"2024-12-31","value":-232.96,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Gross Profit	-	(5.33%)	(16.28%)	(2.69%)	8.32%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-64.03,"profit":false},{"date":"2023-12-31","value":-195.59,"profit":false},{"date":"2024-12-31","value":-32.32,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Gross Margin	-	(0.01%)	10.55%	(5.69%)	(0.36%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-0.07,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-53.94,"profit":false},{"date":"2025-12-31","value":-3.46,"profit":false}]

Operating Expenses	-	11.39%	(7.68%)	10.42%	55.28%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":20.6,"profit":true},{"date":"2023-12-31","value":-13.89,"profit":false},{"date":"2024-12-31","value":18.85,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Income	-	(84.99%)	(320.45%)	191.43%	271.79%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-31.27,"profit":false},{"date":"2023-12-31","value":-117.9,"profit":false},{"date":"2024-12-31","value":70.43,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Pre-Tax Income	-	(73.33%)	(43.90%)	(461.59%)	504.89%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-14.52,"profit":false},{"date":"2023-12-31","value":-8.7,"profit":false},{"date":"2024-12-31","value":-91.42,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Income Taxes	-	(45.45%)	(23.78%)	(204.99%)	(2134.99%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]
Income After Taxes	-	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(81.07%)	87.57%	(260.58%)	1066.53%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-7.6,"profit":false},{"date":"2023-12-31","value":8.21,"profit":true},{"date":"2024-12-31","value":-24.43,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	-	(81.07%)	(60.02%)	(853.29%)	1066.53%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-7.6,"profit":false},{"date":"2023-12-31","value":-5.63,"profit":false},{"date":"2024-12-31","value":-80.01,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

EPS (Diluted)	-	(79.31%)	(56.33%)	(714.12%)	1059.11%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-7.49,"profit":false},{"date":"2023-12-31","value":-5.32,"profit":false},{"date":"2024-12-31","value":-67.43,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Total Revenue	53.19M	50.04M	52.59M	56.26M	57.22M	[{"date":"2024-12-31","value":92.95,"profit":true},{"date":"2025-03-31","value":87.46,"profit":true},{"date":"2025-06-30","value":91.91,"profit":true},{"date":"2025-09-30","value":98.33,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Cost of Revenue	2.59M	3.52M	4.49M	2.95M	3.83M	[{"date":"2024-12-31","value":57.72,"profit":true},{"date":"2025-03-31","value":78.47,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":65.83,"profit":true},{"date":"2025-12-31","value":85.42,"profit":true}]
Gross Profit	50.59M	46.52M	48.10M	53.30M	53.38M	[{"date":"2024-12-31","value":94.78,"profit":true},{"date":"2025-03-31","value":87.14,"profit":true},{"date":"2025-06-30","value":90.11,"profit":true},{"date":"2025-09-30","value":99.85,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Gross Margin	95.13%	92.96%	91.47%	94.75%	93.30%	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":97.72,"profit":true},{"date":"2025-06-30","value":96.15,"profit":true},{"date":"2025-09-30","value":99.6,"profit":true},{"date":"2025-12-31","value":98.08,"profit":true}]

Operating Expenses	60.87M	91.07M	86.61M	84.59M	93.74M	[{"date":"2024-12-31","value":64.94,"profit":true},{"date":"2025-03-31","value":97.15,"profit":true},{"date":"2025-06-30","value":92.39,"profit":true},{"date":"2025-09-30","value":90.24,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Income	(10.28M)	(44.55M)	(38.50M)	(31.28M)	(40.35M)	[{"date":"2024-12-31","value":-1027900000,"profit":false},{"date":"2025-03-31","value":-4454900000,"profit":false},{"date":"2025-06-30","value":-3850300000,"profit":false},{"date":"2025-09-30","value":-3128400000,"profit":false},{"date":"2025-12-31","value":-4035300000,"profit":false}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Pre-Tax Income	(6.50M)	(37.37M)	(34.89M)	(28.39M)	(38.00M)	[{"date":"2024-12-31","value":-649700000,"profit":false},{"date":"2025-03-31","value":-3736800000,"profit":false},{"date":"2025-06-30","value":-3488700000,"profit":false},{"date":"2025-09-30","value":-2839000000,"profit":false},{"date":"2025-12-31","value":-3800200000,"profit":false}]
Income Taxes	(1.58M)	(7.87M)	(7.68M)	(5.80M)	103.19M	[{"date":"2024-12-31","value":-1.54,"profit":false},{"date":"2025-03-31","value":-7.63,"profit":false},{"date":"2025-06-30","value":-7.44,"profit":false},{"date":"2025-09-30","value":-5.62,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Income From Continuous Operations	(4.91M)	(29.49M)	(27.21M)	(22.59M)	(141.19M)	[{"date":"2024-12-31","value":-491200000,"profit":false},{"date":"2025-03-31","value":-2949400000,"profit":false},{"date":"2025-06-30","value":-2720700000,"profit":false},{"date":"2025-09-30","value":-2258600000,"profit":false},{"date":"2025-12-31","value":-14118700000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	(4.91M)	(29.49M)	(27.21M)	(22.59M)	(141.19M)	[{"date":"2024-12-31","value":-491200000,"profit":false},{"date":"2025-03-31","value":-2949400000,"profit":false},{"date":"2025-06-30","value":-2720700000,"profit":false},{"date":"2025-09-30","value":-2258600000,"profit":false},{"date":"2025-12-31","value":-14118700000,"profit":false}]

EPS (Diluted)	(0.08)	(0.50)	(0.46)	(0.38)	(2.39)	[{"date":"2024-12-31","value":-8,"profit":false},{"date":"2025-03-31","value":-50,"profit":false},{"date":"2025-06-30","value":-46,"profit":false},{"date":"2025-09-30","value":-38,"profit":false},{"date":"2025-12-31","value":-239,"profit":false}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Total Revenue	-	(5.91%)	5.09%	6.97%	1.70%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-84.76,"profit":false},{"date":"2025-06-30","value":73.03,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":24.41,"profit":true}]
Cost of Revenue	-	35.95%	27.44%	(34.17%)	29.76%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":76.32,"profit":true},{"date":"2025-09-30","value":-95.05,"profit":false},{"date":"2025-12-31","value":82.78,"profit":true}]
Gross Profit	-	(8.05%)	3.40%	10.81%	0.15%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-74.49,"profit":false},{"date":"2025-06-30","value":31.47,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":1.37,"profit":true}]
Gross Margin	-	(2.28%)	(1.61%)	3.59%	(1.53%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-63.48,"profit":false},{"date":"2025-06-30","value":-44.85,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-42.61,"profit":false}]

Operating Expenses	-	49.60%	(4.90%)	(2.33%)	10.81%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-9.88,"profit":false},{"date":"2025-09-30","value":-4.7,"profit":false},{"date":"2025-12-31","value":21.8,"profit":true}]
Operating Income	-	333.40%	(13.57%)	(18.75%)	28.99%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-4.07,"profit":false},{"date":"2025-09-30","value":-5.62,"profit":false},{"date":"2025-12-31","value":8.7,"profit":true}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Pre-Tax Income	-	475.16%	(6.64%)	(18.62%)	33.86%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-1.4,"profit":false},{"date":"2025-09-30","value":-3.92,"profit":false},{"date":"2025-12-31","value":7.13,"profit":true}]
Income Taxes	-	396.78%	(2.46%)	(24.43%)	(1877.83%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-0.62,"profit":false},{"date":"2025-09-30","value":-6.16,"profit":false},{"date":"2025-12-31","value":-473.26,"profit":false}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	500.45%	(7.75%)	(16.98%)	525.11%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":95.3,"profit":true},{"date":"2025-06-30","value":-1.48,"profit":false},{"date":"2025-09-30","value":-3.23,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	-	500.45%	(7.75%)	(16.98%)	525.11%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":95.3,"profit":true},{"date":"2025-06-30","value":-1.48,"profit":false},{"date":"2025-09-30","value":-3.23,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

EPS (Diluted)	-	525.00%	(8.00%)	(17.39%)	528.95%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":99.25,"profit":true},{"date":"2025-06-30","value":-1.51,"profit":false},{"date":"2025-09-30","value":-3.29,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Total Assets
Current Assets	478.30M	519.29M	432.95M	438.89M	347.26M	[{"date":"2021-12-31","value":92.11,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.37,"profit":true},{"date":"2024-12-31","value":84.52,"profit":true},{"date":"2025-12-31","value":66.87,"profit":true}]
Non-current Assets	115.49M	114.95M	215.49M	217.31M	141.69M	[{"date":"2021-12-31","value":53.14,"profit":true},{"date":"2022-12-31","value":52.9,"profit":true},{"date":"2023-12-31","value":99.16,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":65.2,"profit":true}]
Total Assets	593.79M	634.25M	648.44M	656.20M	488.95M	[{"date":"2021-12-31","value":90.49,"profit":true},{"date":"2022-12-31","value":96.65,"profit":true},{"date":"2023-12-31","value":98.82,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":74.51,"profit":true}]

Total Liabilities
Current Liabilities	74.42M	91.44M	87.70M	99.98M	145.16M	[{"date":"2021-12-31","value":51.27,"profit":true},{"date":"2022-12-31","value":62.99,"profit":true},{"date":"2023-12-31","value":60.41,"profit":true},{"date":"2024-12-31","value":68.88,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Liabilities	14.45M	15.61M	15.83M	17.68M	16.60M	[{"date":"2021-12-31","value":81.72,"profit":true},{"date":"2022-12-31","value":88.32,"profit":true},{"date":"2023-12-31","value":89.57,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":93.91,"profit":true}]
Total Liabilities	88.86M	107.05M	103.53M	117.66M	161.76M	[{"date":"2021-12-31","value":54.94,"profit":true},{"date":"2022-12-31","value":66.18,"profit":true},{"date":"2023-12-31","value":64,"profit":true},{"date":"2024-12-31","value":72.74,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	56.00K	57.00K	58.00K	58.00K	59.00K	[{"date":"2021-12-31","value":94.92,"profit":true},{"date":"2022-12-31","value":96.61,"profit":true},{"date":"2023-12-31","value":98.31,"profit":true},{"date":"2024-12-31","value":98.31,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Retained Earnings	(164.18M)	(157.90M)	(155.39M)	(174.29M)	(394.77M)	[{"date":"2021-12-31","value":-16417600000,"profit":false},{"date":"2022-12-31","value":-15790100000,"profit":false},{"date":"2023-12-31","value":-15539200000,"profit":false},{"date":"2024-12-31","value":-17429200000,"profit":false},{"date":"2025-12-31","value":-39476600000,"profit":false}]
Other Stockholders' Equity	669.22M	686.24M	700.27M	712.71M	721.26M	[{"date":"2021-12-31","value":92.78,"profit":true},{"date":"2022-12-31","value":95.14,"profit":true},{"date":"2023-12-31","value":97.09,"profit":true},{"date":"2024-12-31","value":98.81,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Shareholders' equity	504.93M	527.20M	544.91M	538.55M	327.19M	[{"date":"2021-12-31","value":92.66,"profit":true},{"date":"2022-12-31","value":96.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":98.83,"profit":true},{"date":"2025-12-31","value":60.04,"profit":true}]

Total Liabilities & Shareholders Equity	593.79M	634.25M	648.44M	656.20M	488.95M	[{"date":"2021-12-31","value":90.49,"profit":true},{"date":"2022-12-31","value":96.65,"profit":true},{"date":"2023-12-31","value":98.82,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":74.51,"profit":true}]

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Total Assets
Current Assets	-	8.57%	(16.63%)	1.37%	(20.88%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-194.02,"profit":false},{"date":"2024-12-31","value":16.02,"profit":true},{"date":"2025-12-31","value":-243.6,"profit":false}]
Non-current Assets	-	(0.46%)	87.46%	0.84%	(34.80%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-0.53,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":0.97,"profit":true},{"date":"2025-12-31","value":-39.79,"profit":false}]
Total Assets	-	6.81%	2.24%	1.20%	(25.49%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":32.85,"profit":true},{"date":"2024-12-31","value":17.57,"profit":true},{"date":"2025-12-31","value":-374.11,"profit":false}]

Total Liabilities
Current Liabilities	-	22.87%	(4.09%)	14.01%	45.19%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":50.6,"profit":true},{"date":"2023-12-31","value":-9.05,"profit":false},{"date":"2024-12-31","value":31,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Liabilities	-	8.09%	1.41%	11.65%	(6.09%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":69.43,"profit":true},{"date":"2023-12-31","value":12.1,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":-52.31,"profit":false}]
Total Liabilities	-	20.46%	(3.29%)	13.65%	37.48%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":54.59,"profit":true},{"date":"2023-12-31","value":-8.77,"profit":false},{"date":"2024-12-31","value":36.4,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	1.79%	1.75%	-	1.72%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.25,"profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":96.55,"profit":true}]
Retained Earnings	-	(3.82%)	(1.59%)	12.16%	126.50%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-3.02,"profit":false},{"date":"2023-12-31","value":-1.26,"profit":false},{"date":"2024-12-31","value":9.62,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	2.54%	2.05%	1.78%	1.20%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.48,"profit":true},{"date":"2024-12-31","value":69.84,"profit":true},{"date":"2025-12-31","value":47.24,"profit":true}]
Total Shareholders' equity	-	4.41%	3.36%	(1.17%)	(39.25%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":76.17,"profit":true},{"date":"2024-12-31","value":-26.48,"profit":false},{"date":"2025-12-31","value":-889.83,"profit":false}]

Total Liabilities & Shareholders Equity	-	6.81%	2.24%	1.20%	(25.49%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":32.85,"profit":true},{"date":"2024-12-31","value":17.57,"profit":true},{"date":"2025-12-31","value":-374.11,"profit":false}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Total Assets
Current Assets	438.89M	407.91M	394.92M	367.50M	347.26M	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":92.94,"profit":true},{"date":"2025-06-30","value":89.98,"profit":true},{"date":"2025-09-30","value":83.73,"profit":true},{"date":"2025-12-31","value":79.12,"profit":true}]
Non-current Assets	217.31M	224.03M	229.82M	233.64M	141.69M	[{"date":"2024-12-31","value":93.01,"profit":true},{"date":"2025-03-31","value":95.88,"profit":true},{"date":"2025-06-30","value":98.37,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":60.64,"profit":true}]
Total Assets	656.20M	631.94M	624.75M	601.14M	488.95M	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":96.3,"profit":true},{"date":"2025-06-30","value":95.21,"profit":true},{"date":"2025-09-30","value":91.61,"profit":true},{"date":"2025-12-31","value":74.51,"profit":true}]

Total Liabilities
Current Liabilities	99.98M	103.92M	121.49M	117.87M	145.16M	[{"date":"2024-12-31","value":68.88,"profit":true},{"date":"2025-03-31","value":71.59,"profit":true},{"date":"2025-06-30","value":83.69,"profit":true},{"date":"2025-09-30","value":81.2,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Liabilities	17.68M	16.60M	16.93M	17.27M	16.60M	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":93.88,"profit":true},{"date":"2025-06-30","value":95.76,"profit":true},{"date":"2025-09-30","value":97.7,"profit":true},{"date":"2025-12-31","value":93.91,"profit":true}]
Total Liabilities	117.66M	120.52M	138.42M	135.14M	161.76M	[{"date":"2024-12-31","value":72.74,"profit":true},{"date":"2025-03-31","value":74.5,"profit":true},{"date":"2025-06-30","value":85.57,"profit":true},{"date":"2025-09-30","value":83.54,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	58.00K	59.00K	59.00K	59.00K	-	[{"date":"2024-12-31","value":98.31,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Retained Earnings	(174.29M)	(203.79M)	(230.99M)	(253.58M)	(394.77M)	[{"date":"2024-12-31","value":-17429200000,"profit":false},{"date":"2025-03-31","value":-20378600000,"profit":false},{"date":"2025-06-30","value":-23099300000,"profit":false},{"date":"2025-09-30","value":-25357900000,"profit":false},{"date":"2025-12-31","value":-39476600000,"profit":false}]
Other Stockholders' Equity	712.71M	714.76M	716.87M	718.98M	-	[{"date":"2024-12-31","value":99.13,"profit":true},{"date":"2025-03-31","value":99.41,"profit":true},{"date":"2025-06-30","value":99.71,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Total Shareholders' equity	538.55M	511.42M	486.33M	466.00M	327.19M	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":94.96,"profit":true},{"date":"2025-06-30","value":90.3,"profit":true},{"date":"2025-09-30","value":86.53,"profit":true},{"date":"2025-12-31","value":60.75,"profit":true}]

Total Liabilities & Shareholders Equity	656.20M	631.94M	624.75M	601.14M	488.95M	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":96.3,"profit":true},{"date":"2025-06-30","value":95.21,"profit":true},{"date":"2025-09-30","value":91.61,"profit":true},{"date":"2025-12-31","value":74.51,"profit":true}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Total Assets
Current Assets	-	(7.06%)	(3.18%)	(6.94%)	(5.51%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]
Non-current Assets	-	3.09%	2.59%	1.66%	(39.36%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":83.81,"profit":true},{"date":"2025-09-30","value":53.8,"profit":true},{"date":"2025-12-31","value":-1274.3,"profit":false}]
Total Assets	-	(3.70%)	(1.14%)	(3.78%)	(18.66%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	3.94%	16.90%	(2.98%)	23.15%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":17.03,"profit":true},{"date":"2025-06-30","value":73,"profit":true},{"date":"2025-09-30","value":-12.87,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Liabilities	-	(6.12%)	2.00%	2.03%	(3.89%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-301.81,"profit":false},{"date":"2025-06-30","value":98.73,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-191.74,"profit":false}]
Total Liabilities	-	2.43%	14.85%	(2.37%)	19.70%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":12.34,"profit":true},{"date":"2025-06-30","value":75.39,"profit":true},{"date":"2025-09-30","value":-12.01,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	1.72%	-	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Retained Earnings	-	16.92%	13.35%	9.78%	55.68%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":30.39,"profit":true},{"date":"2025-06-30","value":23.98,"profit":true},{"date":"2025-09-30","value":17.56,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	0.29%	0.29%	0.29%	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":97.86,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":99.99,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	(5.04%)	(4.91%)	(4.18%)	(29.79%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	(3.70%)	(1.14%)	(3.78%)	(18.66%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Operating Activities
Net Operating Cash Flow	64.21M	31.98M	12.80M	(15.76M)	(109.44M)	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":49.81,"profit":true},{"date":"2023-12-31","value":19.93,"profit":true},{"date":"2024-12-31","value":-24.54,"profit":false},{"date":"2025-12-31","value":-170.43,"profit":false}]

Investing Activities
Net Investing Cash Flow	(76.70M)	49.92M	(12.06M)	(17.43M)	94.86M	[{"date":"2021-12-31","value":-80.85,"profit":false},{"date":"2022-12-31","value":52.63,"profit":true},{"date":"2023-12-31","value":-12.71,"profit":false},{"date":"2024-12-31","value":-18.37,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	3.55M	734.00K	605.00K	(155.00K)	(2.91M)	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":20.68,"profit":true},{"date":"2023-12-31","value":17.04,"profit":true},{"date":"2024-12-31","value":-4.37,"profit":false},{"date":"2025-12-31","value":-81.86,"profit":false}]

Net Change in Cash	(9.02M)	82.96M	792.00K	(33.51M)	(17.46M)	[{"date":"2021-12-31","value":-10.87,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":0.95,"profit":true},{"date":"2024-12-31","value":-40.39,"profit":false},{"date":"2025-12-31","value":-21.05,"profit":false}]

Free Cash Flow
Free Cash Flow	63.66M	31.30M	12.42M	(16.25M)	(110.44M)	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":49.17,"profit":true},{"date":"2023-12-31","value":19.51,"profit":true},{"date":"2024-12-31","value":-25.52,"profit":false},{"date":"2025-12-31","value":-173.48,"profit":false}]

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(50.19%)	(59.98%)	(223.09%)	594.56%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-8.44,"profit":false},{"date":"2023-12-31","value":-10.09,"profit":false},{"date":"2024-12-31","value":-37.52,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(165.09%)	(124.15%)	44.58%	(644.23%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-370.37,"profit":false},{"date":"2023-12-31","value":-278.51,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":-1445.27,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(79.32%)	(17.57%)	(125.62%)	1774.84%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-4.47,"profit":false},{"date":"2023-12-31","value":-0.99,"profit":false},{"date":"2024-12-31","value":-7.08,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

Net Change in Cash	-	(1020.02%)	(99.05%)	(4330.43%)	(47.87%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(50.83%)	(60.33%)	(230.83%)	579.76%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-8.77,"profit":false},{"date":"2023-12-31","value":-10.41,"profit":false},{"date":"2024-12-31","value":-39.82,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Operating Activities
Net Operating Cash Flow	(1.82M)	(33.15M)	(15.25M)	(31.63M)	(29.42M)	[{"date":"2024-12-31","value":-181700000,"profit":false},{"date":"2025-03-31","value":-3314700000,"profit":false},{"date":"2025-06-30","value":-1525200000,"profit":false},{"date":"2025-09-30","value":-3162600000,"profit":false},{"date":"2025-12-31","value":-2941700000,"profit":false}]

Investing Activities
Net Investing Cash Flow	3.99M	43.90M	(15.27M)	21.36M	-	[{"date":"2024-12-31","value":9.1,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-34.78,"profit":false},{"date":"2025-09-30","value":48.66,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	(155.00K)	(1.32M)	(425.00K)	(517.00K)	(640.00K)	[{"date":"2024-12-31","value":-15500000,"profit":false},{"date":"2025-03-31","value":-132400000,"profit":false},{"date":"2025-06-30","value":-42500000,"profit":false},{"date":"2025-09-30","value":-51700000,"profit":false},{"date":"2025-12-31","value":-64000000,"profit":false}]

Net Change in Cash	1.82M	9.48M	(30.81M)	(10.96M)	14.83M	[{"date":"2024-12-31","value":12.27,"profit":true},{"date":"2025-03-31","value":63.93,"profit":true},{"date":"2025-06-30","value":-207.79,"profit":false},{"date":"2025-09-30","value":-73.92,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(2.03M)	(33.58M)	(15.55M)	(31.79M)	(29.52M)	[{"date":"2024-12-31","value":-203100000,"profit":false},{"date":"2025-03-31","value":-3358300000,"profit":false},{"date":"2025-06-30","value":-1555100000,"profit":false},{"date":"2025-09-30","value":-3178700000,"profit":false},{"date":"2025-12-31","value":-2951900000,"profit":false}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Operating Activities
Net Operating Cash Flow	-	1724.27%	(53.99%)	107.36%	(6.98%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-3.13,"profit":false},{"date":"2025-09-30","value":6.23,"profit":true},{"date":"2025-12-31","value":-0.41,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	999.47%	(134.78%)	(239.90%)	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-13.49,"profit":false},{"date":"2025-09-30","value":-24,"profit":false},{"date":"2025-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	754.19%	(67.90%)	21.65%	23.79%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-9,"profit":false},{"date":"2025-09-30","value":2.87,"profit":true},{"date":"2025-12-31","value":3.15,"profit":true}]

Net Change in Cash	-	421.17%	(425.03%)	(64.43%)	(235.29%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-100.92,"profit":false},{"date":"2025-09-30","value":-15.3,"profit":false},{"date":"2025-12-31","value":-55.87,"profit":false}]

Free Cash Flow
Free Cash Flow	-	1553.52%	(53.69%)	104.40%	(7.13%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-3.46,"profit":false},{"date":"2025-09-30","value":6.72,"profit":true},{"date":"2025-12-31","value":-0.46,"profit":false}]

Vanda Pharmaceuticals Inc Ratios

Vanda Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	VNDA
Current Ratio	2.39
Quick Ratio	2.38

Vanda Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	VNDA
ROA (LTM)	-16.50%
ROE (LTM)	-50.93%

Vanda Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	VNDA
Debt Ratio Lower is generally better. Negative is bad.	0.33
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.67

Vanda Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	VNDA
Trailing PE	NM
Forward PE	103.09
P/S (TTM)	1.70
P/B	1.10
Price/FCF	NM
EV/R	0.50
EV/Ebitda	12.91
PEG	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Vanda Pharmaceuticals Inc share price today?

Vanda Pharmaceuticals Inc (VNDA) share price today is $6.2

Can Indians buy Vanda Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Vanda Pharmaceuticals Inc (VNDA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VNDA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Vanda Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Vanda Pharmaceuticals Inc (VNDA) via the Vested app. You can start investing in Vanda Pharmaceuticals Inc (VNDA) with a minimum investment of $1.

How to invest in Vanda Pharmaceuticals Inc shares from India?

You can invest in shares of Vanda Pharmaceuticals Inc (VNDA) via Vested in three simple steps:

Click on Sign Up or Invest in VNDA stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Vanda Pharmaceuticals Inc shares

What is Vanda Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Vanda Pharmaceuticals Inc (VNDA) is $9.6. The 52-week low price of Vanda Pharmaceuticals Inc (VNDA) is $3.81.

What is Vanda Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Vanda Pharmaceuticals Inc (VNDA) is

What is Vanda Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Vanda Pharmaceuticals Inc (VNDA) is 1.10

What is Vanda Pharmaceuticals Inc dividend yield?

The dividend yield of Vanda Pharmaceuticals Inc (VNDA) is 0.00%

What is the Market Cap of Vanda Pharmaceuticals Inc?

The market capitalization of Vanda Pharmaceuticals Inc (VNDA) is $359.97M

What is Vanda Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of Vanda Pharmaceuticals Inc is VNDA

How Can Investors Use Vanda Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Vanda Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Vanda Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Vanda Pharmaceuticals Inc shares for Indian investors?

When investing in Vanda Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Vanda Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Vanda Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Vanda Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Vanda Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Vanda Pharmaceuticals Inc Share Price

Vanda Pharmaceuticals Inc Analyst Forecast

Vanda Pharmaceuticals Inc Share Price Chart

Vanda Pharmaceuticals Inc Key Stock Metrics

About Vanda Pharmaceuticals Inc, Common Stock

Vanda Pharmaceuticals Inc Stock Returns

Vanda Pharmaceuticals Inc Financials

Vanda Pharmaceuticals Inc Ratios

Vanda Pharmaceuticals Inc Liquidity Ratios

Vanda Pharmaceuticals Inc Asset Efficiency Ratios

Vanda Pharmaceuticals Inc Liability Ratios

Vanda Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Vanda Pharmaceuticals Inc Share Price

Vanda Pharmaceuticals Inc Analyst Forecast

Vanda Pharmaceuticals Inc Share Price Chart

Vanda Pharmaceuticals Inc Key Stock Metrics

About Vanda Pharmaceuticals Inc, Common Stock

Vanda Pharmaceuticals Inc Stock Returns

Vanda Pharmaceuticals Inc Financials

Vanda Pharmaceuticals Inc Ratios

Vanda Pharmaceuticals Inc Liquidity Ratios

Vanda Pharmaceuticals Inc Asset Efficiency Ratios

Vanda Pharmaceuticals Inc Liability Ratios

Vanda Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²